The Cologuard® test can enrich follow-up colonoscopy patient populations1-4
Positive Cologuard results produced1-4:
Significantly higher rate of precancer diagnoses*
More clinically relevant precancer diagnoses†
More histologically advanced findings‡
Compared to average-risk screening colonoscopy and colonoscopy following a positive FIT result.1-4
CRC Screening Quiz
How well do you know the current screening facts? Let’s find out.
Cologuard-first screening can help prioritize colonoscopy for patients who need it most.1-4
Use the Cologuard test to help enhance the quality of detection of early-stage colorectal cancer (CRC) and precancer during follow-up colonoscopy.1,5
All panelists are paid speakers, presenting on behalf of Exact Sciences. Views, opinions, and information provided during this presentation are based on the speakers’ own clinical practice and experience and are not clinical, diagnostic, or treatment advice for any particular event. Exact Sciences does not recommend or endorse any particular course of treatment or medical choice.
View updated guidance for cost-sharing for a follow-up colonoscopy
Cologuard patient outcomes
Find out how the Cologuard test can improve patient outcomes
- Overall neoplasia diagnosis in colonoscopies after a positive mt-sDNA test was 15% higher vs screening colonoscopy (47% vs 32%, respectively).4
- Colonoscopies following positive mt-sDNA results detected 12% more clinically relevant serrated polyps vs colonoscopy only (20.9% vs 8.6%, respectively).2
- Patients with positive mt-sDNA results had more histologically advanced findings vs those with positive FIT results (P=0.0054) and those who only underwent colonoscopy (P<0.0001).1
FIT=fecal immunochemical test.